Related Experiment Videos
Fluvastatin titrate-to-goal clinical practice study.
1Androscoggin Cardiology Associates, Auburn, ME 04210, USA.
American Journal of Therapeutics
|March 31, 1999
Summary
Fluvastatin effectively lowers LDL cholesterol in patients with moderate hypercholesterolemia. This study confirms fluvastatin
Area of Science:
- Cardiology
- Pharmacology
Background:
- Moderate hypercholesterolemia poses cardiovascular risks.
- Dietary interventions are a first step in management.
- Pharmacological options are needed for persistent high cholesterol.
Purpose of the Study:
- To evaluate the efficacy and safety of fluvastatin.
- To assess fluvastatin's impact on lipid profiles.
- To determine fluvastatin's suitability for general practice patients.
Main Methods:
- Open-label, multicenter trial.
- 1776 patients aged 18-75 years.
- 12-week fluvastatin treatment after dietary stabilization.
Main Results:
- Low-density lipoprotein cholesterol decreased by 21%.
- Total cholesterol and triglycerides reduced by 14%.
- Adverse effects were minimal, with no study terminations due to lab abnormalities.
Conclusions:
- Fluvastatin is effective in treating moderate hypercholesterolemia.
- Fluvastatin demonstrates a favorable safety profile.
- Fluvastatin is a suitable option for general practice settings.